Closed · PAR-23-268 · CFDA 93.350 · Discretionary

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed

Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.

up to $296K
Award range
Closed
Status
December 9, 2025
Close date
-
Expected awards

The verdict

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed is a closed discretionary listing from National Institutes of Health that offered Up to $295,924. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.

up to $296K
award range
Closed
application status
93.350
CFDA program
12,419
other opportunities from National Institutes of Health

Recently closed NOFO

This listing closed on December 9, 2025. Watch CFDA 93.350 (Mental Health National Research Service Awards) for the next funding cycle. Historical award band was Up to $295,924.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed December 9, 2025

Posted Apr 18 Closes Dec 9

Instrument

Cooperative Agreement

Description

This FOA provides support using the STTR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated the ability for specific and targeted tissue and organ repair, which can be harnessed for applications such as extracellular vesicle-based therapeutics. The main objective for this funding opportunity is to support platform-oriented technology development associated with the production, manufacturing, and use, of extracellular vesicles as therapeutics in regenerative medicine.

Small-business / for-profit corridor · PAR-23-268

Industrialization and Translation of Extracel… prints a for-profit / small-business applicant door (Small businesses). Treat the listing as business-facing unless the full Grants.gov announcement narrows it further. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). 789 other National Institutes of Health listings share this eligibility-code string (6% of 12,420).

Code 23
Small businesses

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

NIH Grants Information grantsinfo@nih.gov

What to do next

Industrialization and Translation of Extracel… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.350 may publish future NOFOs under the same assistance listing. Open program
  • Mental Health National Research Service Awards indexes 26 Grants.gov listings in this extract. Program profile
  • National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants